KITE PHARMA H-1B Visa Sponsorship & Salary Data

The median H-1B salary at KITE PHARMA is $118,914, based on 307 certified filings from FY 2020 to FY 2026. This is 1% lower than the national H-1B median salary of $120,000. Compensation at KITE PHARMA reflects their market positioning, with entry-level roles starting around $94,955 and senior positions reaching $181,813 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at KITE PHARMA range from $81,390 at the 10th percentile to $181,813 at the 90th percentile, showing a $100,423 spread across experience levels and roles. The 25th percentile is $94,955 and the 75th percentile is $144,997.

Yes, KITE PHARMA actively sponsors H-1B visas and has been a consistent participant in the H-1B program. They have filed 310 H-1B labor condition applications from FY 2020 to FY 2026, demonstrating ongoing commitment to hiring international talent. With 307 certified applications and a 0.3% denial rate, KITE PHARMA maintains a strong track record for H-1B sponsorship. The company sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2026), KITE PHARMA filed 4 H-1B applications, with 4 certified and 0 denied. Over 7 years of data, KITE PHARMA has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

KITE PHARMA's LCA (Labor Condition Application) denial rate is 0.3%, with 1 out of 310 applications denied across all years. This translates to a 99.7% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating KITE PHARMA as a potential H-1B sponsor.

This is an excellent approval rate, indicating KITE PHARMA has strong H-1B sponsorship practices and typically meets DOL requirements. Applicants can feel confident in the company's H-1B track record.

KITE PHARMA sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 307 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles KITE PHARMA most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at KITE PHARMA:

The most frequently sponsored role is Senior Research Associate with 26 filings at a median salary of $91,822. This is followed by Research Scientist (20 filings) and Senior Chemical Engineer.

KITE PHARMA's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where KITE PHARMA sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top KITE PHARMA H-1B locations:

The largest H-1B hub for KITE PHARMA is Santa Monica, CA with 138 filings at a median salary of $118,914. The highest-paying location is Raleigh, NC at $156,922 median. Salaries range from $89,912 to $156,922 across office locations.

KITE PHARMA's median H-1B salary has increased by +41% from FY 2020 ($102,589) to FY 2026 ($144,880). Tracking salary trends over time reveals how KITE PHARMA adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at KITE PHARMA.

Year-by-year breakdown:

• FY 2022: $111,099 (59 certified)
• FY 2023: $126,277 (54 certified)
• FY 2024: $128,000 (47 certified)
• FY 2025: $134,576 (52 certified)
• FY 2026: $144,880 (4 certified)

This 41% growth reflects strong compensation adjustments at KITE PHARMA, keeping pace with market demands for H-1B talent.

KITE PHARMA primarily files H-1B applications at Wage Level IV, accounting for 42% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making KITE PHARMA's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

With 98% of positions at Level II or higher, KITE PHARMA typically offers competitive wages above entry-level. Higher wage levels receive priority in the H-1B lottery.

KITE PHARMA's median H-1B salary of $118,914 is 1% lower than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating KITE PHARMA's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare KITE PHARMA's offerings with similar companies in your field for a more accurate assessment.

KITE PHARMA's H-1B salaries are competitive with industry averages. The 307 total filings indicate active H-1B sponsorship.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. KITE PHARMA's higher proportion of Level III-IV positions (72%) may benefit from wage-based lottery prioritization.

With 307 certified filings, KITE PHARMA invests significantly in H-1B sponsorship. The company's 0.3% denial rate suggests strong compliance with H-1B requirements and documentation standards.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.